Predisposition to prolonged neutropenia after chemotherapy for paediatric acute myeloid leukaemia is associated with better prognosis in the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study

被引：4

作者：

Aoki, Takahiro ^{[1
]}

Takahashi, Hiroyuki ^{[2
]}

Tanaka, Shiro ^{[3
]}

Shiba, Norio ^{[4
]}

Hasegawa, Daiichiro ^{[5
]}

Iwamoto, Shotaro ^{[6
]}

Terui, Kiminori ^{[7
]}

Moritake, Hiroshi ^{[8
]}

Nakayama, Hideki ^{[9
]}

Shimada, Akira ^{[10
]}

Koh, Katsuyoshi ^{[11
]}

Goto, Hiroaki ^{[12
]}

Kosaka, Yoshiyuki ^{[5
]}

Saito, Akiko M. ^{[13
]}

Horibe, Keizo ^{[13
]}

Kinoshita, Akitoshi ^{[14
]}

Tawa, Akio ^{[15
]}

Taga, Takashi ^{[16
]}

Adachi, Souichi ^{[17
]}

Tomizawa, Daisuke ^{[18
]}

机构：

[1] Chiba Univ, Grad Sch Med, Dept Pediat, Chiba, Japan

[2] Toho Univ, Dept Pediat, Tokyo, Japan

[3] Kyoto Univ, Grad Sch Med, Dept Clin Biostat, Clin Biostat Course, Kyoto, Japan

[4] Yokohama City Univ Med, Grad Sch Med, Dept Pediat, Yokohama, Kanagawa, Japan

[5] Hyogo Prefectural Kobe Childrens Hosp, Dept Hematol Oncol, Kobe, Hyogo, Japan

[6] Mie Univ, Dept Pediat, Tsu, Mie, Japan

[7] Hirosaki Univ, Dept Pediat, Hirosaki, Aomori, Japan

[8] Univ Miyazaki, Fac Med, Div Pediat, Miyazaki, Japan

[9] Natl Hosp Org, Dept Pediat, Kyushu Canc Ctr, Fukuoka, Japan

[10] Okayama Univ Hosp, Dept Pediat Hematol Oncol, Okayama, Japan

[11] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama, Japan

[12] Kanagawa Childrens Med Ctr, Div Hematol Oncol, Yokohama, Kanagawa, Japan

[13] Natl Hosp Org, Clin Res Ctr, Nagoya Med Ctr, Nagoya, Aichi, Japan

[14] St Marianna Univ, Sch Med, Dept Pediat, Kawasaki, Kanagawa, Japan

[15] Higashiosaka Aramoto Heiwa Clin, Higashiosaka, Osaka, Japan

[16] Shiga Univ Med Sci, Dept Pediat, Otsu, Shiga, Japan

[17] Kyoto Univ, Dept Human Hlth Sci, Kyoto, Japan

[18] Natl Ctr Child Hlth & Dev, Childrens Canc Ctr, Div Leukemia & Lymphoma, Tokyo, Japan

来源：

BRITISH JOURNAL OF HAEMATOLOGY | 2021年 / 193卷 / 01期

关键词：

acute myeloid leukaemia; chemosensitivity; children; myelosuppression; neutropenia; LYMPHOBLASTIC-LEUKEMIA; CHILDREN; RELAPSE; THERAPY;

D O I：

10.1111/bjh.16656

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

The variability in myelosuppression after chemotherapy for acute myeloid leukaemia (AML) can affect its prognosis; however, the underlying mechanism remains controversial. In the Japanese Paediatric Leukaemia/Lymphoma Study Group AML-05 study, we showed that prolonged neutropenia was associated with high overall survival (P = 0 center dot 011) and low frequency of relapse (P = 0 center dot 042) in patients without granulocyte-colony stimulating factor (G-CSF) who completed the indicated treatment protocol. Our data indicate that predisposition to prolonged neutropenia after chemotherapy is correlated with a better outcome of AML treatment. Our results promote the usage of individualised drug dosing strategies to improve the therapeutic outcome in AML patients.

引用

页码：176 / 180

页数：5

共 50 条

[21] Validation of the 'French Acute Lymphoblastic Leukaemia Study Group FRALLE prognostic index' for paediatric Philadelphia-chromosome acute lymphoblastic leukaemia
Rives, Susana
Camos, Mireia
Estella, Jesus
Gomez, Pedro
Lopez-Duarte, Monica
Navajas, Aurora
Badell, Isabel
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (02) : 284 - 286
[22] Low Frequency and Poor Prognosis Of MLL-Partial Tandem Duplications In Pediatric Acute Myeloid Leukemia Using MLPA Method: The Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG) AML-05 Trial
Ohki, Kentaro
Park, Myoung-ja
Sano, Hitoshi
Hara, Yusuke
Shiba, Norio
Tomizawa, Daisuke
Taga, Takashi
Saito, Akiko Moriya
Fujimoto, Junichiro
Tawa, Akio
Horibe, Keizo
Adachi, Souichi
Hayashi, Yasuhide
BLOOD, 2013, 122 (21)
[23] Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study
Chaleff, Stanley
Hurwitz, Craig A.
Chang, Myron
Dahl, Gary
Alonzo, Todd A.
Weinstein, Howard
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (05) : 649 - 655
[24] Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
M Tokumasu
C Murata
A Shimada
K Ohki
Y Hayashi
A M Saito
J Fujimoto
K Horibe
M Nagao
H Itoh
Y Kamikubo
H Nakayama
A Kinoshita
D Tomizawa
T Taga
A Tawa
S Tanaka
T Heike
S Adachi
Leukemia, 2015, 29 : 2438 - 2441
[25] Osteonecrosis in Korean Paediatric and Young Adults with Acute Lymphoblastic Leukaemia or Lymphoblastic Lymphoma: A Nationwide Epidemiological Study
Hahn, Seung Min
Lee, Myeongjee
Huser, Aaron
Gim, Yeonji
Kim, Eun Hwa
Kim, Minsoo
Aldosari, Amaal M.
Jung, Inkyung
Kwak, Yoon Hae
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (09)
[26] Outcome in 146 patients with paediatric acute myeloid leukaemia treated according to the AML99 protocol in the period 2003-06 from the Japan Association of Childhood Leukaemia Study
Imamura, Toshihiko
Iwamoto, Shotaro
Kanai, Rie
Shimada, Akira
Terui, Kiminori
Osugi, Yuko
Kobayashi, Ryoji
Tawa, Akio
Kosaka, Yoshiyuki
Kato, Koji
Hori, Hiroki
Horibe, Keizo
Oda, Megumi
Adachi, Souichi
BRITISH JOURNAL OF HAEMATOLOGY, 2012, 159 (02) : 204 - 210
[27] High DOCK1 expression identifies a distinct prognostic subgroup of pediatric acute myeloid leukemia: Results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
Yoshitomi, Masahiro
Tsujimoto, Shin-Ichi
Ikeda, Junji
Kawai, Tomoko
Ohki, Kentaro
Hara, Yusuke
Yamato, Genki
Tanoshima, Reo
Tomizawa, Daisuke
Shimada, Akira
Horibe, Keizo
Adachi, Souichi
Taga, Takashi
Tawa, Akio
Hayashi, Yasuhide
Ito, Shuichi
Shiba, Norio
PEDIATRIC BLOOD & CANCER, 2024, 71 (09)
[28] Adverse prognostic impact of KIT mutations in childhood CBF-AML: the results of the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 trial
Tokumasu, M.
Murata, C.
Shimada, A.
Ohki, K.
Hayashi, Y.
Saito, A. M.
Fujimoto, J.
Horibe, K.
Nagao, M.
Itoh, H.
Kamikubo, Y.
Nakayama, H.
Kinoshita, A.
Tomizawa, D.
Taga, T.
Tawa, A.
Tanaka, S.
Heike, T.
Adachi, S.
LEUKEMIA, 2015, 29 (12) : 2438 - 2441
[29] High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group
Adam Gassas
Ponni Sivaprakasam
Michelle Cummins
Patricia Breslin
Katharine Patrick
Mary Slatter
Roderick Skinner
Geof Shenton
Brenda Gibson
Sarah Lawson
Toni Petterson
Michael Potter
Beki James
Rachael Hough
Prashant Hiwarkar
Ajay Vora
Paul Veys
Josu De La Fuente
Robert Wynn
Persis Amrolia
Bone Marrow Transplantation, 2018, 53 : 1165 - 1169
[30] High transplant-related mortality associated with haematopoietic stem cell transplantation for paediatric therapy-related acute myeloid leukaemia (t-AML). A study on behalf of the United Kingdom Paediatric Blood and Bone Marrow Transplant Group
Gassas, Adam
Sivaprakasam, Ponni
Cummins, Michelle
Breslin, Patricia
Patrick, Katharine
Slatter, Mary
Skinner, Roderick
Shenton, Geof
Gibson, Brenda
Lawson, Sarah
Petterson, Toni
Potter, Michael
James, Beki
Hough, Rachael
Hiwarkar, Prashant
Vora, Ajay
Veys, Paul
De la Fuente, Josu
Wynn, Robert
Amrolia, Persis
BONE MARROW TRANSPLANTATION, 2018, 53 (09) : 1165 - 1169

← 1 2 3 4 5 →